A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

For advancements to be made in pathophysiology and medication development of Parkinson’s disease, reliable disease models need ... By consistently adapting to new regulatory challenges and guidelines, ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

The earlier Parkinson's disease is spotted, the better – for patients, their loved ones, and scientists working toward ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

Most treatments for Parkinson's disease (PD) only slow disease progression. Early intervention for the neurological disease ...

Diagnosing Parkinson's disease has always been a race against time. The later it’s found, the harder it is to treat.